share_log
Moomoo 24/7 ·  Apr 24 16:02
FibroGen To Present Data From Dose Escalation Phase 1b Study of FG-3246 Plus Enzalutamide At 2024 American Society of Clinical Oncology Annual Meeting May 31-Jun. 4
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment